Asthma control | 4 weeks | 12 weeks | ||
---|---|---|---|---|
n | % | n | % | |
Montelukast monotherapy | ||||
All patients, n (%) | (N = 75) | (N = 68) | ||
Well controlled | 46 | 61.3 | 51 | 75.0 |
Not controlled | 29 | 38.7 | 17 | 25.0 |
Preschool aged patients, n (%) | (N = 34) | (N =32 ) | ||
Well controlled | 19 | 55.9 | 24 | 75.0 |
Not controlled | 15 | 44.1 | 8 | 25.0 |
School aged patients, n (%) | (N =41 ) | (N = 36) | ||
Well controlled | 27 | 65.9 | 27 | 75.0 |
Not controlled | 14 | 34.1 | 9 | 25.0 |
Montelukast + ICS | ||||
All patients, n (%) | (N = 244) | (N = 220) | ||
Well controlled | 129 | 52.9 | 156 | 70.9 |
Not controlled | 115 | 47.1 | 64 | 29.1 |
Preschool aged patients, n (%) | (N = 105) | (N = 96) | ||
Well controlled | 69 | 65.7 | 75 | 78.1 |
Not controlled | 36 | 34.3 | 21 | 21.9 |
School aged patients, n (%) | (N = 139) | (N = 124) | ||
Well controlled | 60 | 43.2 | 81 | 65.3 |
Not controlled | 79 | 56.8 | 43 | 34.7 |
Total study sample (Montelukast monotherapy & Montelukast + ICS) | ||||
All patients, n (%) | (N = 319) | (N = 288) | ||
Well controlled | 175 | 54.9 | 207 | 71.9 |
Not controlled | 144 | 45.1 | 81 | 28.1 |
Preschool aged patients, n (%) | (N = 139) | (N = 128) | ||
Well controlled | 88 | 63.3 | 99 | 77.3 |
Not controlled | 51 | 36.7 | 29 | 22.7 |
School aged patients, n (%) | (N = 180) | (N = 160) | ||
Well controlled | 87 | 48.3 | 108 | 67.5 |
Not controlled | 93 | 51.7 | 52 | 32.5 |